{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-097505","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2023-12-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.421923+00:00","generated_at":"2026-06-07T08:48:37.878598+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Oramed receives $5M first principal payment on $101.9M Scilex Note; next $15M due March 21, 2024","bullets":["Received $5 million first principal payment on December 21, 2023, under Senior Secured Promissory Note from Scilex.","Next principal payment of $15 million expected on March 21, 2024.","Note principal amount $101,875,000, due 18 months from issuance (September 21, 2023).","Payments are part of Securities Purchase Agreement consummated on September 21, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-097505","json":"https://secwatch.observer/filing/0001213900-23-097505.json","markdown":"https://secwatch.observer/filing/0001213900-23-097505.md","text":"https://secwatch.observer/filing/0001213900-23-097505.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390023097505/0001213900-23-097505-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390023097505/ea190496-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T08:48:37.878598+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}